References
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.
- World Health Organization: International Agency for Research on Cancer. Available from: https://www. iarc.who.int [Last accessed on 2023 Aug 10].
- Badar F, Mahmood S. Cancer in Lahore, Pakistan, 2010–2019: An incidence study. BMJ Open 2022;11:e047049.
- Shaukat Khanum Memorial Cancer Hospital and Research Centre: Lahore, Pakistan. Available from: https://shaukatkhanum.org.pk [Last accessed on 2023 May 12].
- Bhushan A, Gonsalves A, Menon JU. Current state of breast cancer diagnosis, treatment, and theranostics. Pharmaceutics 2021;13:723.
- ASCO Guidelines. Available from: https://asco guidelines(ascopubs.org) [Last accessed on 2023 May 12].
- Waks AG, Winer EP. Breast cancer treatment: A review. JAMA 2019;321:288-300.
- Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK. Various types and management of breast cancer: An overview. J Adv Pharm Technol Res 2010;1:109-26.
- Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
- Jung W, Kang E, Kim SM, Kim D, Hwang Y, Sun Y, et al. Factors associated with re-excision after breast-conserving surgery for early-stage breast cancer. J Breast Cancer 2012;15:412-9.
- McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014;383:2127-35.
- Azu M, Abrahamse P, Katz SJ, Jagsi R, Morrow M. What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol 2010;17:558-63.
- McCahill LE, Privette A, James T, Sheehey-Jones J, Ratliff J, Majercik D, et al. Quality measures for breast cancer surgery: Initial validation of feasibility and assessment of variation among surgeons. Arch Surg 2009;144:455-62, discussion 462-3.
- McCahill LE, Single RM, Aiello Bowles EJ, Feigelson HS, James TA, Barney T, et al. Variability in reexcision following breast conservation surgery. JAMA 2012;307:467-75.
- Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 2009;302:1551-6.
- Lovelace DL, McDaniel LR, Golden D. Long-term effects of breast cancer surgery, treatment, and survivor care. J Midwifery Womens Health 2019;64:713-24.
- Rosenberger LH, Mamtani A, Fuzesi S, Stempel M, Eaton A, Morrow M, et al. Early adoption of the SSO-ASTRO consensus guidelines on margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: Initial experience from Memorial Sloan Kettering Cancer Center. Ann Surg Oncol 2016;23:3239-46.
- Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, et al. Society of surgical oncology-American society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys 2010;88:553-64.
- Schulman AM, Mirrielees JA, Leverson G, Landercasper J, Greenberg C, Wilke LG. Reexcision surgery for breast cancer: An analysis of the American Society of Breast Surgeons (ASBrS) Mastery SM database following the SSO-ASTRO “no ink on tumor” guidelines. Ann Surg Oncol 2017;24:52-8.
- Patten CR, Walsh K, Sarantou T, Hadzikadic-Gusic L, Forster MR, Robinson M, et al. Changes in margin re-excision rates: Experience incorporating the “no ink on tumor” guideline into practice. J Surg Oncol 2017;116:1040-5.
- Havel L, Naik H, Ramirez L, Morrow M, Landercasper J. Impact of the SSO-ASTRO margin guideline on rates of re-excision after lumpectomy for breast cancer: A meta-analysis. Ann Surg Oncol 2019;26:1238-44.
- Reid VJ, Falk JS, Police AM, Ridgeway CA, Cadena LL, Povoski SP. Minimizing re-excision after breast conserving surgery-a review of radiofrequency spectroscopy for real-time, intraoperative margin assessment. Expert Rev Med Devices 2021;18: 1057-68.
- Dumitru D, Douek M, Benson JR. Novel techniques for intraoperative assessment of margin involvement. Ecancermedicalscience 2018;12:795.
- Schnabel F, Boolbol SK, Gittleman M, Karni T, Tafra L, Feldman S, et al. A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies. Ann Surg Oncol 2014;21:1589-95.
- Olsen MA, Nickel KB, Margenthaler JA, Wallace AE, Mines D, Miller JP, et al. Increased risk of surgical site infection among breast-conserving surgery re-excisions. Ann Surg Oncol 2015;22:2003-9.
- Abe SE, Hill JS, Han Y, Walsh K, Symanowski JT, Hadzikadic-Gusic L, et al. Margin re-excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model. J Surg Oncol 2015;112:443-8.
- Buchholz TA, Somerfield MR, Griggs JJ, El-Eid S, Hammond ME, Lyman GH, et al. Margins for breast-conserving surgery with whole-breast irradiation in stage I and II invasive breast cancer: American Society of Clinical Oncology endorsement of the Society of Surgical Oncology/American Society for Radiation Oncology consensus guideline. J Clin Oncol 2014;32:1502-6.
- Baliski C, Bakos B. Patient reported outcomes following breast conserving surgery are improved by minimizing re-excisions and excessive breast tissue removal. Am J Surg 2022;224:716-21.
- De La Cruz L, Blankenship SA, Chatterjee A, Geha R, Nocera N, Czerniecki BJ, et al. Outcomes after oncoplastic breast-conserving surgery in breast cancer patients: A systematic literature review. Ann Surg Oncol 2016;23:3247-58.
- Acea-Nebril B, Cereijo-Garea C, García-Novoa A, Varela-Lamas C, Builes-Ramírez S, Bouzón-Alejandro A, et al. The role of oncoplastic breast reduction in the conservative management of breast cancer: Complications, survival, and quality of life. J Surg Oncol 2017;115:679-86.
- Calì Cassi L, Vanni G, Petrella G, Orsaria P, Pistolese C, Lo Russo G, et al. Comparative study of oncoplastic versus non-oncoplastic breast conserving surgery in a group of 211 breast cancer patients. Eur Rev Med Pharmacol Sci 2016;20:2950-4.
- Kelemen P, Pukancsik D, Újhelyi M, Sávolt Á, Kovács E, Ivády G, et al. Comparison of clinicopathologic, cosmetic and quality of life outcomes in 700 oncoplastic and conventional breast-conserving surgery cases: A single-centre retrospective study. Eur J Surg Oncol 2019;45:118-24.
- Kiruparan N, Kiruparan P, Debnath D. Use of wire-guided and radio-guided occult lesion localization for non-palpable breast lesions: A systematic literature review and meta-analysis of current evidence. Asian J Surg 2022;45:79-88.
- Buonomo O, Cabassi A, Guadagni F, Piazza A, Felici A, Piccirillo R, et al. Radioguided-surgery of early breast lesions. Anticancer Res 2001;21:2091-7.
- Vanni G, Pellicciaro M, Materazzo M, Dauri M, D’angelillo RM, Buonomo C, et al. Awake breast cancer surgery: Strategy in the beginning of COVID-19 emergency. Breast Cancer 2021;28:137-44.
- Vanni G, Tazzioli G, Pellicciaro M, Materazzo M, Paolo O, Cattadori F, et al. Delay in breast cancer treatments during the first COVID-19 Lockdown. A multicentric analysis of 432 patients. Anticancer Res 2020;40:7119-25.